Startup · $18.8m raised
Australian medtech startup developing hydrogel condoms
Sydney, NSW
Every investor coverage indicates participated in a round Eudaemon Technologies raised.
| Investor | Rounds | Invested |
|---|---|---|
| Angel Investors | Unnamed stage | - |
| Swinburne Ventures Limited | Unnamed stage | - |
Companies Eudaemon Technologies acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Nick Northcott | Executive Chairman | Wholesale Investor, SmartCompany |
Stories naming Eudaemon Technologies. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of a Sydney-based medical device maker developing a hydrogel condom, noting its human safety trial, manufacturing build-out, patent portfolio and grant backing.
Weekly roundup: Firmus completes its $2.85b round; Procore acquires DroneDeploy; Atlassian rebounds while Canva cuts guidance; plus fresh raises for Zabidou, BioScout, Vexev, Enrola, Spacetalk and others.
Roundup of four Australian raises: Firmus Technologies' US$2 billion round at a $15 billion valuation, Eudaemon's $3.75 million, Zabidou's $3.5 million seed round, and Rampart's $2.3 million.
An executive interview with KP Rx founder Hashan De Silva on building a specialist healthcare venture firm investing in biotech and medical devices across Australia and New Zealand.